Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.9205
Delayed Data
As of 3:59pm ET
 -0.0095 / -1.02%
Today’s Change
0.82
Today|||52-Week Range
3.50
-26.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-114.4M-107.0M-52.7M-15.0M
 
 
 
 
 
Depreciation2.5M3.8M6.2M9.6M
 
 
 
 
 
Total Other Cash Flow10.9M5.4M10.8M2.3M
 
 
 
 
 
Funds From Operations-101.0M-97.8M-35.7M-3.1M
 
 
 
 
 
Funds From/For Other Operating Expenses4.7M-13.4M19.2M18.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-105.7M-84.4M-54.8M-21.2M
 
 
 
 
 
 
InvestingIncrease In Investments-194.6M-175.4M-42.3M-19.1M
 
 
 
 
 
Decrease In Investments339.8M191.1M109.8M11.6M
 
 
 
 
 
Capital Expenditures-9.9M-3.7M-12.9M-22.0K
 
 
 
 
 
Fixed Asset Disposal----191.0K1.2M
 
 
 
Net Cash Flow Investing135.2M12.1M54.7M-6.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings3.7M0.008.6M0.00
 
 
 
Long Term Debt Reduction-2.2M-7.1M-7.8M-11.6M
 
 
 
 
 
Net Proceeds Stock Sale1.6M53.6M191.0K10.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00465.0K0.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing3.1M47.0M1.0M-1.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-26.0K26.0K0.000.00
 
 
 
 
Net Change In Cash32.7M-25.3M882.0K-28.7M